2,4,6-Trimethylpyridine → HCID 59458858、化合物

HRID 1712825ノート

反応式

HRID 1712825 の反応式
[Si:1]([N:8]1[C:11](=[O:12])[CH2:10][C@@H:9]1[C:13]([OH:15])=O)([C:4]([CH3:7])([CH3:6])[CH3:5])([CH3:3])[CH3:2].ClC(Cl)(OC(=O)OC(Cl)(Cl)Cl)Cl.CC1C=C(C)C=C(C)N=1.[F:37][C:38]1[CH:39]=[C:40]([C@:46]([C:55]2[CH:60]=[C:59]([O:61][C:62]([F:67])([F:66])[CH:63]([F:65])[F:64])[CH:58]=[C:57]([F:68])[CH:56]=2)([NH2:54])[CH2:47][C:48]2[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=2)[CH:41]=[CH:42][C:43]=1[O:44][CH3:45].C(N(CC)C(C)C)(C)C>C1COCC1.O>[Si:1]([N:8]1[C:11](=[O:12])[CH2:10][C@@H:9]1[C:13]([NH:54][C@:46]([C:40]1[CH:41]=[CH:42][C:43]([O:44][CH3:45])=[C:38]([F:37])[CH:39]=1)([C:55]1[CH:60]=[C:59]([O:61][C:62]([F:67])([F:66])[CH:63]([F:65])[F:64])[CH:58]=[C:57]([F:68])[CH:56]=1)[CH2:47][C:48]1[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=1)=[O:15])([C:4]([CH3:5])([CH3:6])[CH3:7])([CH3:2])[CH3:3]

参加物

8

実験手順

To a solution of (R)-1-(tert-butyldimethylsilyl)-4-oxoazetidine-2-carboxylic acid (126 mg, 0.55 mmol) in THF (1.5 mL) was added to a solution of triphosgene (54 mg, 0.18 mmol). The reaction mixture was stirred for 5 min at rt, followed by addition of 2,4,6-trimethylpyridine (203 μL, 1.54 mmol), a solution of (R)-1-(3-fluoro-4-methoxyphenyl)-1-(3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl)-2-phenylethanamine, prepared as described in Procedure 3, 62, 5 and 6, (50 mg, 0.11 mmol) in THF (0.6 mL), and N,N-diisopropylethylamine (268 μL, 1.54 mmol). The reaction mixture was stirred at room temperature for 40 min. Water (10 mL) was added and the reaction mixture was extracted with dichloromethane (3×15 mL) and the combined organic layers were washed with 2 N potassium carbonate and then sat. NaCl. The organic layers were dried over magnesium sulfate, filtered and concentrated under reduced pressure. The residue was purified by ISCO Flash chromatography (Analogix column 4.2 g, eluting with hexane/EtOAc) to yield (R)-1-(tert-Butyldimethylsilyl)-N-((R)-1-(3-fluoro-4-methoxyphenyl)-1-(3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl)-2-phenylethyl)-4-oxoazetidine-2-carboxamide (Example 343, 41 mg, 55% yield). LCMS: RT=4.18 min [M+H] 667.1 (Phenominex, Luna C18, 4.6×50 mm, 10%-90% MeOH/H2O containing 0.1% TFA, flow rate 4 mL/min, 4 min gradient, monitoring at 220 nm); 1H NMR (500 MHz, CDCl3) δ ppm −0.04 (s, 3H), 0.24 (s, 3H), 0.91 (s, 9H), 2.79 (dd, J=15.4, 2.7 Hz, 1H), 3.32 (dd, J=15.4, 6.6 Hz, 1H), 3.79-3.85 (m, 1H), 3.86-3.90 (m, 2H), 3.91 (s, 3H), 5.87 (none, 2H), 6.59 (s, 1H), 6.64 (d, J=7.1 Hz, 2H), 6.75 (s, 1H), 6.80 (d, J=9.3 Hz, 1H), 6.87-6.94 (m, 4H), 7.15 (t, J=7.4 Hz, 2H), 7.20 (d, J=7.1 Hz, 1H).

後処理

  1. stirringThe reaction mixture was stirred at room temperature for 40 min
  2. extractionthe reaction mixture was extracted with dichloromethane (3×15 mL)
  3. washthe combined organic layers were washed with 2 N potassium carbonate
  4. dry with materialThe organic layers were dried over magnesium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated under reduced pressure
  7. customThe residue was purified by ISCO Flash chromatography (Analogix column 4.2 g, eluting with hexane/EtOAc)

出典と根拠

ORDレコード
ord-2498df61da7b408f88fd7528ed69af2a
出典データセット
uspto-grants-2010_09
特許番号
US07790770B2

反応ノート

読み込み中…